FDA Inspection 1220868 — Generitech Corporation
The FDA completed an inspection of Generitech Corporation on September 29, 2023 in Fresno, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fresno, CA (United States)